Advisors Preferred, LLC Moderna, Inc. Transaction History

Advisors Preferred, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$118.07 - $194.18 $12,397 - $20,388	105 New	105 $13,000
Q2 2022 Aug 11, 2022	SELL	$117.13 - $176.59 $139,267 - $209,965	-1,189 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$126.46 - $235.05 $150,360 - $279,474	1,189 New	1,189 $210,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisors Preferred, LLC with notifications on news.